Raymond J. Henley Iii

Array ( [id] => 4261592 [patent_doc_number] => 06258848 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Methods and compositions for increasing insulin sensitivity' [patent_app_type] => 1 [patent_app_number] => 9/364637 [patent_app_country] => US [patent_app_date] => 1999-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5093 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258848.pdf [firstpage_image] =>[orig_patent_app_number] => 364637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186304 [patent_doc_number] => 06160015 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Compounds useful in the treatment of neurofibromatosis' [patent_app_type] => 1 [patent_app_number] => 9/361959 [patent_app_country] => US [patent_app_date] => 1999-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 33349 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/160/06160015.pdf [firstpage_image] =>[orig_patent_app_number] => 361959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183932 [patent_doc_number] => 06150333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Methods of using a somatostatin analogue' [patent_app_type] => 1 [patent_app_number] => 9/361394 [patent_app_country] => US [patent_app_date] => 1999-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2442 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150333.pdf [firstpage_image] =>[orig_patent_app_number] => 361394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4115008 [patent_doc_number] => 06046160 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Composition and method for enhancing wound healing' [patent_app_type] => 1 [patent_app_number] => 9/358777 [patent_app_country] => US [patent_app_date] => 1999-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11255 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046160.pdf [firstpage_image] =>[orig_patent_app_number] => 358777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4118809 [patent_doc_number] => 06071918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence' [patent_app_type] => 1 [patent_app_number] => 9/357748 [patent_app_country] => US [patent_app_date] => 1999-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5971 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071918.pdf [firstpage_image] =>[orig_patent_app_number] => 357748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157266 [patent_doc_number] => 06114344 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Long-acting local anesthetics' [patent_app_type] => 1 [patent_app_number] => 9/356283 [patent_app_country] => US [patent_app_date] => 1999-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2463 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114344.pdf [firstpage_image] =>[orig_patent_app_number] => 356283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217464 [patent_doc_number] => 06087363 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Use of imidazole and indole compounds as inhibitors of nitric oxide synthase' [patent_app_type] => 1 [patent_app_number] => 9/356171 [patent_app_country] => US [patent_app_date] => 1999-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4323 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087363.pdf [firstpage_image] =>[orig_patent_app_number] => 356171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260788 [patent_doc_number] => 06204281 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Method of treatment and pharmaceutical composition' [patent_app_type] => 1 [patent_app_number] => 9/349654 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3442 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204281.pdf [firstpage_image] =>[orig_patent_app_number] => 349654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4088214 [patent_doc_number] => 06017961 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Ketamine and n-butyl-p-aminobezoate in PLO' [patent_app_type] => 1 [patent_app_number] => 9/350062 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3740 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017961.pdf [firstpage_image] =>[orig_patent_app_number] => 350062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103800 [patent_doc_number] => 06100274 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => '8-chloro-6,11-dihydro-11- ] (4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions' [patent_app_type] => 1 [patent_app_number] => 9/348943 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3880 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100274.pdf [firstpage_image] =>[orig_patent_app_number] => 348943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235136 [patent_doc_number] => 06075005 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Medicaments comprising relaxin and their use' [patent_app_type] => 1 [patent_app_number] => 9/348062 [patent_app_country] => US [patent_app_date] => 1999-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5459 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075005.pdf [firstpage_image] =>[orig_patent_app_number] => 348062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186373 [patent_doc_number] => 06042823 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Enzyme composition and use thereof' [patent_app_type] => 1 [patent_app_number] => 9/340203 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4213 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/042/06042823.pdf [firstpage_image] =>[orig_patent_app_number] => 340203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4216665 [patent_doc_number] => 06110927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Loratadine for use as an antiarrhythmic' [patent_app_type] => 1 [patent_app_number] => 9/342007 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3104 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110927.pdf [firstpage_image] =>[orig_patent_app_number] => 342007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360559 [patent_doc_number] => 06255325 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Chronic, bolus administration of D-threo methylphenidate' [patent_app_type] => 1 [patent_app_number] => 9/337310 [patent_app_country] => US [patent_app_date] => 1999-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5256 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255325.pdf [firstpage_image] =>[orig_patent_app_number] => 337310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4298697 [patent_doc_number] => 06184397 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Preparation of sterol and stanol-esters' [patent_app_type] => 1 [patent_app_number] => 9/336773 [patent_app_country] => US [patent_app_date] => 1999-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4650 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184397.pdf [firstpage_image] =>[orig_patent_app_number] => 336773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032822 [patent_doc_number] => 05994407 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Procedure to prepare a solution with capsaicin' [patent_app_type] => 1 [patent_app_number] => 9/333657 [patent_app_country] => US [patent_app_date] => 1999-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 300 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994407.pdf [firstpage_image] =>[orig_patent_app_number] => 333657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089626 [patent_doc_number] => 06133267 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications' [patent_app_type] => 1 [patent_app_number] => 9/319881 [patent_app_country] => US [patent_app_date] => 1999-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2386 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133267.pdf [firstpage_image] =>[orig_patent_app_number] => 319881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217987 [patent_doc_number] => 06087393 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Stabilized vitamin C formulations' [patent_app_type] => 1 [patent_app_number] => 9/329608 [patent_app_country] => US [patent_app_date] => 1999-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2580 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087393.pdf [firstpage_image] =>[orig_patent_app_number] => 329608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217710 [patent_doc_number] => 06087377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea' [patent_app_type] => 1 [patent_app_number] => 9/329554 [patent_app_country] => US [patent_app_date] => 1999-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2150 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087377.pdf [firstpage_image] =>[orig_patent_app_number] => 329554 [rel_patent_id] =>[rel_patent_doc_number] =>)